Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-22-026326)

Filing Details

Accession Number:: 0001127602-22-026326
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2022-11-23 14:53:16
Reporting Period:: 2022-08-01

Accepted Time:: 2022-11-23 14:53:16
Original Submission Date:: 2022-08-02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1878313	Maia Biotechnology Inc.	MAIA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1913257	Vlad Vitoc	444 West Lake Street, Chicago IL 60606	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-01	6,000	$5.00	789,121	No	4	P	Direct
Common Stock	Acquisiton	2022-08-01	10,000	$5.00	210,000	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See Footnote

Footnotes

These shares were purchased in the issuer's initial public offering, which closed on August 1, 2022.
These securities are beneficially owned by Mr. Vitoc's spouse. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.